What is the current COVID-19 IgM & IgG Rapid Test Kits market size?

The COVID-19 IgM & IgG Rapid Test Kits market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the COVID-19 IgM & IgG Rapid Test Kits market?

Key drivers include rising COVID-19 cases and growing awareness of rapid testing kits.

What are the major challenges facing the market?

Challenges include intense competition, regulatory hurdles, and supply chain disruptions.

Which regions are leading the COVID-19 IgM & IgG Rapid Test Kits market?

North America and Europe are regional leaders, driven by advanced healthcare infrastructure.

Who are the top companies in the market?

Top companies include Abbott, Roche, and Siemens, offering high-quality rapid test kits.

What future opportunities exist in the market?

Future opportunities include emerging markets and innovative technologies, driving future outlook.

How is technology impacting the COVID-19 IgM & IgG Rapid Test Kits market?

Technology is improving test kit accuracy, speed, and affordability, enhancing market growth.

What is the current regulatory landscape for the market?

The regulatory landscape is evolving, with stringent guidelines and approvals required for test kits.

COVID-19 IgM & IgG Rapid Test Kits Growth Analysis & Future Outlook 2033

COVID-19 IgM & IgG Rapid Test Kits by Application (Hospital, Special Clinic, Research Institutions), by Types (RDT(Rapid Diagnostic Test), ELISA(Enzyme-linked Immunosorbent Aassay), Neutralization Assay), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 123

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

COVID-19 IgM & IgG Rapid Test Kits Market Overview

The COVID-19 IgM & IgG Rapid Test Kits market is a crucial segment of the global diagnostics industry, playing a vital role in the rapid detection of COVID-19 antibodies. As the world continues to grapple with the pandemic, the COVID-19 IgM & IgG Rapid Test Kits market size is estimated to be approximately $1.4 billion in 2025. The growth outlook for this market is promising, with a market forecast indicating a significant expansion during the forecast period of 2026-2033. The industry expansion is driven by the increasing demand for rapid and accurate diagnostic tests, with a compound annual growth rate (CAGR) expected to be around 10-12%. Key forces shaping the industry include technology shifts towards point-of-care diagnostics, regulatory approvals, and changing consumer behavior towards healthcare.

Loading chart…

The largest region for the COVID-19 IgM & IgG Rapid Test Kits market is currently North America, driven by the high demand for diagnostic tests in the United States. The fastest-growing region is expected to be the Asia-Pacific, driven by the increasing healthcare expenditure and growing awareness about COVID-19 diagnostics in countries such as China and India. The market is expected to witness significant growth during the forecast period, driven by the increasing adoption of rapid diagnostic tests, advancements in technology, and the rising demand for point-of-care diagnostics. Key players in the market are focusing on developing innovative products and expanding their distribution networks to capitalize on the growing demand for COVID-19 IgM & IgG Rapid Test Kits.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cellex; RayBiotech; Biopanda; BioMedomics; GenBody; SD Biosensor; Advaite; Premier Biotech; Epitope Diagnostics; CTK Biotech; Creative Diagnostics; Eagle Biosciences; Sure Biotech; Sugentech; Sensing self; Euroimmun AG; PharmACT; Liming Bio; Beijing Wantai; Livzon Diagnostics; Shenzhen BioEasy Biotechnology; Orient Gene Biotech; INNOVITA; Dynamiker; Guangzhou Wonfo Bio-Tech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The COVID-19 IgM & IgG Rapid Test Kits market is experiencing significant fluctuations due to various dynamics. Understanding these factors is crucial for stakeholders to navigate the market effectively.

Growth Drivers2 items

Increasing demand for rapid diagnostic tests due to the ongoing COVID-19 pandemic is driving the market growth, with the COVID-19 IgM & IgG Rapid Test Kits market size expected to expand significantly over the forecast period.

Advancements in technology have improved the accuracy and efficiency of COVID-19 IgM & IgG Rapid Test Kits, making them a preferred choice for diagnosis, which in turn is contributing to the growth forecast of the market.

Restraints2 items

Stringent regulatory requirements and the need for approvals from authorities such as the FDA can hinder the launch of new COVID-19 IgM & IgG Rapid Test Kits, thereby restraining the market growth.

The high cost associated with the development and production of rapid test kits can limit their adoption in resource-poor settings, affecting the overall COVID-19 IgM & IgG Rapid Test Kits market size.

Opportunities2 items

The rising awareness about the importance of early diagnosis and treatment of COVID-19 presents opportunities for manufacturers to develop and market innovative COVID-19 IgM & IgG Rapid Test Kits.

Expanding operations into emerging economies where the demand for rapid diagnostic tests is increasing can provide new avenues for growth for companies in the COVID-19 IgM & IgG Rapid Test Kits market.

Challenges2 items

Ensuring the accuracy and reliability of COVID-19 IgM & IgG Rapid Test Kits is a significant challenge due to the rapid pace of mutations in the SARS-CoV-2 virus, which can impact the growth forecast.

Managing supply chains effectively to meet the sudden surges in demand for COVID-19 IgM & IgG Rapid Test Kits without compromising on quality is a logistical challenge faced by manufacturers, affecting the overall COVID-19 IgM & IgG Rapid Test Kits market.

Market Segmentation

Loading chart…

The Application segment of the COVID-19 IgM & IgG Rapid Test Kits market refers to the various uses of these kits, including clinical diagnosis, research, and surveillance. This segmentation category contributes significantly to the overall market size, as different applications have distinct requirements for test kits, driving demand for specific products. Understanding the COVID-19 IgM & IgG Rapid Test Kits segmentation by application is crucial for manufacturers to tailor their products to meet the needs of different end-users.

The Types segment of the COVID-19 IgM & IgG Rapid Test Kits market encompasses various subtypes, such as [object Object] and [object Object]. This segmentation category is vital in determining the market taxonomy, as different types of test kits have varying levels of sensitivity, specificity, and usability. The types segment contributes to the overall market size by catering to diverse customer preferences and requirements, making it essential for market players to understand the dynamics of this segment to stay competitive in the COVID-19 IgM & IgG Rapid Test Kits market.

COVID-19 IgM & IgG Rapid Test Kits Segmentation Breakdown8 items

Application

Hospital

Special Clinic

Research Institutions

Types

RDT(Rapid Diagnostic Test)

ELISA(Enzyme-linked Immunosorbent Aassay)

Neutralization Assay

Regional Insights

Loading chart…

The COVID-19 IgM & IgG Rapid Test Kits market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, driven by key drivers such as high adoption rates, government policies supporting the use of rapid test kits, and significant investments in healthcare infrastructure. The fastest-growing region is expected to be Latin America, with a growth rate driven by increasing demographics and improving ecosystem maturity.

In North America, key drivers include infrastructure development, policies supporting the use of rapid test kits, and high adoption rates, contributing to a market share of around 25%. Europe is expected to account for approximately 20% of the market share, driven by factors such as investments in research and development, demographics, and ecosystem maturity. The Middle East & Africa region is expected to account for around 15% of the market share, driven by growing adoption rates and improving infrastructure.

Competitive Landscape

The COVID-19 IgM & IgG Rapid Test Kits market is moderately consolidated, with a mix of global players and local/regional companies competing for market share. The COVID-19 IgM & IgG Rapid Test Kits competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on expanding their product portfolios and strengthening their distribution networks, while local players are leveraging their regional presence and cost advantages to compete.

Companies in this market are adopting various strategies to differentiate themselves and gain a competitive edge. Common strategies include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. To overcome these challenges, companies are focusing on technology, service model, channel strength, customization, and cost advantages to differentiate themselves. The following companies are notable for their strategic focus:

Cellex: regional expansion

RayBiotech: innovation pipeline

Biopanda: premium pricing

BioMedomics: OEM tie-ups

GenBody: local manufacturing

SD Biosensor: vertical integration

Key COVID-19 IgM & IgG Rapid Test Kits Companies25 items

Cellex

RayBiotech

Biopanda

BioMedomics

GenBody

SD Biosensor

Advaite

Premier Biotech

Epitope Diagnostics

CTK Biotech

Creative Diagnostics

Eagle Biosciences

Sure Biotech

Sugentech

Sensing self

Euroimmun AG

PharmACT

Liming Bio

Beijing Wantai

Livzon Diagnostics

Shenzhen BioEasy Biotechnology

Orient Gene Biotech

INNOVITA

Dynamiker

Guangzhou Wonfo Bio-Tech

Market Ecosystem

The COVID-19 IgM & IgG Rapid Test Kits ecosystem encompasses a complex network of participants, spanning upstream, midstream, and downstream activities. Value creation and capture occur through the interplay of technology providers, suppliers, integrators, channels, and end users. Understanding the boundaries and interactions within this ecosystem is essential for navigating the COVID-19 IgM & IgG Rapid Test Kits ecosystem.

Raw material suppliers — providing critical components

OEMs / manufacturers — producing test kits

Technology providers — developing diagnostic technologies

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering support and maintenance

Regulators/standards bodies — establishing guidelines and approvals

End users / buyers — utilizing test kits for diagnostic purposes

Value flows through the ecosystem as participants interact and exchange goods, services, and information. Control points, such as regulatory approvals and technology standards, influence adoption and shape the competitive landscape. Dependency risks, including input constraints and standards compliance, can create bottlenecks and impact ecosystem participants. Furthermore, switching costs, partnerships, and interoperability requirements can affect the ease with which participants can enter or exit the ecosystem, or switch between different technologies or suppliers, highlighting the need for a thorough value chain analysis to navigate these complexities.

Recent Industry Insights

The COVID-19 IgM & IgG Rapid Test Kits industry trends have witnessed significant developments over the last 12-18 months. Notable partnerships have been formed between leading diagnostic companies to enhance production capabilities and expand distribution networks. Additionally, there have been strategic mergers and acquisitions to consolidate market share and improve research and development efforts.

Recent product launches have focused on improving test accuracy and reducing turnaround times. Regulatory changes have also played a crucial role in shaping the industry, with authorities implementing stricter guidelines for test kit approval and usage. Furthermore, there has been a notable shift in consumer and enterprise trends, with increased demand for rapid testing solutions in various settings, driving the need for innovative and reliable COVID-19 IgM & IgG Rapid Test Kits.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the COVID-19 IgM & IgG Rapid Test Kits market outlook. The market attractiveness is moderate, driven by the ongoing need for rapid diagnosis and the increasing adoption of point-of-care testing. The competitive intensity is high, with numerous players competing for market share. The long-term outlook is promising, with a growing demand for rapid testing solutions. The innovation landscape is evolving, with advancements in technology and the development of new testing methods. However, the demand-supply balance is a concern, with fluctuations in demand and supply chain disruptions. Key risk factors include regulatory changes, intense competition, and the potential for decreased demand as vaccination rates increase.

12 items

1. Executive Summary

2. COVID-19 IgM & IgG Rapid Test Kits Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global COVID-19 IgM & IgG Rapid Test Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global COVID-19 IgM & IgG Rapid Test Kits Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global COVID-19 IgM & IgG Rapid Test Kits Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global COVID-19 IgM & IgG Rapid Test Kits Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global COVID-19 IgM & IgG Rapid Test Kits Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global COVID-19 IgM & IgG Rapid Test Kits Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global COVID-19 IgM & IgG Rapid Test Kits Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global COVID-19 IgM & IgG Rapid Test Kits Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global COVID-19 IgM & IgG Rapid Test Kits Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global COVID-19 IgM & IgG Rapid Test Kits Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global COVID-19 IgM & IgG Rapid Test Kits Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global COVID-19 IgM & IgG Rapid Test Kits Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global COVID-19 IgM & IgG Rapid Test Kits Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global COVID-19 IgM & IgG Rapid Test Kits Market Competition by Key Manufacturers

9.1. Global COVID-19 IgM & IgG Rapid Test Kits Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global COVID-19 IgM & IgG Rapid Test Kits: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Cellex

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. RayBiotech

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Biopanda

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. BioMedomics

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. GenBody

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. SD Biosensor

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Advaite

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Premier Biotech

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Epitope Diagnostics

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. CTK Biotech

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Creative Diagnostics

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Eagle Biosciences

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Sure Biotech

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Sugentech

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Sensing self

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Euroimmun AG

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. PharmACT

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Liming Bio

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Beijing Wantai

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Livzon Diagnostics

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Shenzhen BioEasy Biotechnology

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Orient Gene Biotech

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. INNOVITA

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

10.24. Dynamiker

10.24.1. Company Basic Information and Sales Area

10.24.2. Main Business/Business Overview

10.24.3. Product Portfolio

10.24.4. Financial

10.24.5. Recent Industry Insights

10.24.6. SWOT Analysis

10.25. Guangzhou Wonfo Bio-Tech

10.25.1. Company Basic Information and Sales Area

10.25.2. Main Business/Business Overview

10.25.3. Product Portfolio

10.25.4. Financial

10.25.5. Recent Industry Insights

10.25.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global COVID-19 IgM & IgG Rapid Test Kits Market

Figure 4: Global COVID-19 IgM & IgG Rapid Test Kits Market: Drivers

Figure 5: Global COVID-19 IgM & IgG Rapid Test Kits Market: Challenges

Figure 6: Global COVID-19 IgM & IgG Rapid Test Kits Market: Trends

Figure 7: Global COVID-19 IgM & IgG Rapid Test Kits Market: Opportunity

Figure 8: Global COVID-19 IgM & IgG Rapid Test Kits Market: Restraint

Figure 9: Global COVID-19 IgM & IgG Rapid Test Kits Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global COVID-19 IgM & IgG Rapid Test Kits Market Value (USD Million) By Region

Figure 19: Global COVID-19 IgM & IgG Rapid Test Kits Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global COVID-19 IgM & IgG Rapid Test Kits Market Value (USD Million) By Region

Figure 27: Global COVID-19 IgM & IgG Rapid Test Kits Market Share (%) By: Regions (2032)

Figure 28: Global COVID-19 IgM & IgG Rapid Test Kits Market Volume (K) By Region

Figure 29: Global COVID-19 IgM & IgG Rapid Test Kits Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global COVID-19 IgM & IgG Rapid Test Kits Market Value (USD Million) By Region

Figure 37: Global COVID-19 IgM & IgG Rapid Test Kits Market Share (%) By: Regions (2032)

Figure 38: Global COVID-19 IgM & IgG Rapid Test Kits Market Volume (K) By Region

Figure 39: Global COVID-19 IgM & IgG Rapid Test Kits Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

145 items

Table 1: Market Segmentation Analysis

Table 2: Global COVID-19 IgM & IgG Rapid Test Kits Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global COVID-19 IgM & IgG Rapid Test Kits Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global COVID-19 IgM & IgG Rapid Test Kits Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global COVID-19 IgM & IgG Rapid Test Kits Market Value (USD Million) By Region

Table 14: Global COVID-19 IgM & IgG Rapid Test Kits Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global COVID-19 IgM & IgG Rapid Test Kits Market Volume (K) By Region

Table 31: Global COVID-19 IgM & IgG Rapid Test Kits Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global COVID-19 IgM & IgG Rapid Test Kits Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global COVID-19 IgM & IgG Rapid Test Kits Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global COVID-19 IgM & IgG Rapid Test Kits Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Cellex Basic Information And Sales Area

Table 52: Cellex. Products Portfolio

Table 53: RayBiotech Basic Information And Sales Area

Table 54: RayBiotech. Products Portfolio

Table 55: Biopanda Basic Information And Sales Area

Table 56: Biopanda. Products Portfolio

Table 57: BioMedomics Basic Information And Sales Area

Table 58: BioMedomics. Products Portfolio

Table 59: GenBody Basic Information And Sales Area

Table 60: GenBody. Products Portfolio

Table 61: SD Biosensor Basic Information And Sales Area

Table 62: SD Biosensor. Products Portfolio

Table 63: Advaite Basic Information And Sales Area

Table 64: Advaite. Products Portfolio

Table 65: Premier Biotech Basic Information And Sales Area

Table 66: Premier Biotech. Products Portfolio

Table 67: Epitope Diagnostics Basic Information And Sales Area

Table 68: Epitope Diagnostics. Products Portfolio

Table 69: CTK Biotech Basic Information And Sales Area

Table 70: CTK Biotech. Products Portfolio

Table 71: Creative Diagnostics Basic Information And Sales Area

Table 72: Creative Diagnostics. Products Portfolio

Table 73: Eagle Biosciences Basic Information And Sales Area

Table 74: Eagle Biosciences. Products Portfolio

Table 75: Sure Biotech Basic Information And Sales Area

Table 76: Sure Biotech. Products Portfolio

Table 77: Sugentech Basic Information And Sales Area

Table 78: Sugentech. Products Portfolio

Table 79: Sensing self Basic Information And Sales Area

Table 80: Sensing self. Products Portfolio

Table 81: Euroimmun AG Basic Information And Sales Area

Table 82: Euroimmun AG. Products Portfolio

Table 83: PharmACT Basic Information And Sales Area

Table 84: PharmACT. Products Portfolio

Table 85: Liming Bio Basic Information And Sales Area

Table 86: Liming Bio. Products Portfolio

Table 87: Beijing Wantai Basic Information And Sales Area

Table 88: Beijing Wantai. Products Portfolio

Table 89: Livzon Diagnostics Basic Information And Sales Area

Table 90: Livzon Diagnostics. Products Portfolio

Table 91: Shenzhen BioEasy Biotechnology Basic Information And Sales Area

Table 92: Shenzhen BioEasy Biotechnology. Products Portfolio

Table 93: Orient Gene Biotech Basic Information And Sales Area

Table 94: Orient Gene Biotech. Products Portfolio

Table 95: INNOVITA Basic Information And Sales Area

Table 96: INNOVITA. Products Portfolio

Table 97: Dynamiker Basic Information And Sales Area

Table 98: Dynamiker. Products Portfolio

Table 99: Guangzhou Wonfo Bio-Tech Basic Information And Sales Area

Table 100: Guangzhou Wonfo Bio-Tech. Products Portfolio

Table 101: Global Market Value (USD Million) (2025-2032) By Application

Table 102: Global Market Share (%) By Application (2032)

Table 103: Global Market Value (USD Million) (2025-2032) By Types

Table 104: Global Market Share (%) By Types (2032)

Table 105: Global Market Volume (K) (2025-2032) By Application

Table 106: Global Market Share (%) By Application (2032)

Table 107: Global Market Volume (K) (2025-2032) By Types

Table 108: Global Market Share (%) By Types (2032)

Table 109: Global COVID-19 IgM & IgG Rapid Test Kits Market Value (USD Million) By Region

Table 110: Global COVID-19 IgM & IgG Rapid Test Kits Market Share (%) By Region (2025-2032)

Table 111: North America Market Value (USD Million) (2025-2032) By Country

Table 112: North America Market Value (USD Million) (2025-2032) By Application

Table 113: North America Market Value (USD Million) (2025-2032) By Types

Table 114: Europe Market Value (USD Million) (2025-2032) By Country

Table 115: Europe Market Value (USD Million) (2025-2032) By Application

Table 116: Europe Market Value (USD Million) (2025-2032) By Types

Table 117: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 118: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 119: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 120: South America Market Value (USD Million) (2025-2032) By Country

Table 121: South America Market Value (USD Million) (2025-2032) By Application

Table 122: South America Market Value (USD Million) (2025-2032) By Types

Table 123: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 124: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 125: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 126: Global COVID-19 IgM & IgG Rapid Test Kits Market Volume (K) By Region

Table 127: Global COVID-19 IgM & IgG Rapid Test Kits Market Share (%) By Region (2025-2032)

Table 128: North America Market Volume (K) (2025-2032) By Country

Table 129: North America Market Volume (K) (2025-2032) By Application

Table 130: North America Market Volume (K) (2025-2032) By Types

Table 131: Europe Market Volume (K) (2025-2032) By Country

Table 132: Europe Market Volume (K) (2025-2032) By Application

Table 133: Europe Market Volume (K) (2025-2032) By Types

Table 134: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 135: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 136: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 137: South America Market Volume (K) (2025-2032) By Country

Table 138: South America Market Volume (K) (2025-2032) By Application

Table 139: South America Market Volume (K) (2025-2032) By Types

Table 140: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 141: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 142: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 143: Research Programs/Design For This Report

Table 144: Key Data Information From Secondary Sources

Table 145: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

COVID-19 IgM & IgG Rapid Test Kits Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.61 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cellex; RayBiotech; Biopanda; BioMedomics; GenBody; SD Biosensor; Advaite; Premier Biotech; Epitope Diagnostics; CTK Biotech; Creative Diagnostics; Eagle Biosciences; Sure Biotech; Sugentech; Sensing self; Euroimmun AG; PharmACT; Liming Bio; Beijing Wantai; Livzon Diagnostics; Shenzhen BioEasy Biotechnology; Orient Gene Biotech; INNOVITA; Dynamiker; Guangzhou Wonfo Bio-Tech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

COVID-19 IgM & IgG Rapid Test Kits Segmentation Breakdown8 items

Application

Hospital

Special Clinic

Research Institutions

Types

RDT(Rapid Diagnostic Test)

ELISA(Enzyme-linked Immunosorbent Aassay)

Neutralization Assay

Regional Insights

Loading chart…

Competitive Landscape

Cellex: regional expansion

RayBiotech: innovation pipeline

Biopanda: premium pricing

BioMedomics: OEM tie-ups

GenBody: local manufacturing

SD Biosensor: vertical integration

Key COVID-19 IgM & IgG Rapid Test Kits Companies25 items

Cellex

RayBiotech

Biopanda

BioMedomics

GenBody

SD Biosensor

Advaite

Premier Biotech

Epitope Diagnostics

CTK Biotech

Creative Diagnostics

Eagle Biosciences

Sure Biotech

Sugentech

Sensing self

Euroimmun AG

PharmACT

Liming Bio

Beijing Wantai

Livzon Diagnostics

Shenzhen BioEasy Biotechnology

Orient Gene Biotech

INNOVITA

Dynamiker

Guangzhou Wonfo Bio-Tech

Market Ecosystem

Raw material suppliers — providing critical components

OEMs / manufacturers — producing test kits

Technology providers — developing diagnostic technologies

Distributors / channel partners — delivering products to end users

Service providers / after-sales — offering support and maintenance

Regulators/standards bodies — establishing guidelines and approvals

End users / buyers — utilizing test kits for diagnostic purposes

Recent Industry Insights

Analyst Overview

Table of Contents